Opportunity ID: 320078

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-19-360
Funding Opportunity Title: Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 29, 2019
Last Updated Date: Aug 29, 2019
Original Closing Date for Applications: Sep 07, 2022
Current Closing Date for Applications: Sep 07, 2022
Archive Date: Oct 13, 2022
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
County governments
Public housing authorities/Indian housing authorities
City or township governments
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
Small businesses
Public and State controlled institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Private institutions of higher education
Special district governments
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider’s recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-19-360.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Folder 320078 Full Announcement-PAR-19-360 -> PAR-19-360-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00254326 Sep 17, 2019 May 24, 2020 View
FORMS-F Use for due dates on or before January 24, 2022 PKG00259094 Sep 17, 2019 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269729 Oct 28, 2021 Sep 07, 2022 View

Package 1

Mandatory forms

320078 RR_SF424_2_0-2.0.pdf

320078 PHS398_CoverPageSupplement_4_0-4.0.pdf

320078 RR_OtherProjectInfo_1_4-1.4.pdf

320078 PerformanceSite_2_0-2.0.pdf

320078 RR_KeyPersonExpanded_2_0-2.0.pdf

320078 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

320078 RR_Budget_1_4-1.4.pdf

320078 RR_SubawardBudget30_1_4-1.4.pdf

320078 PHS398_ModularBudget_1_2-1.2.pdf

320078 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

320078 RR_SF424_2_0-2.0.pdf

320078 PHS398_CoverPageSupplement_5_0-5.0.pdf

320078 RR_OtherProjectInfo_1_4-1.4.pdf

320078 PerformanceSite_2_0-2.0.pdf

320078 RR_KeyPersonExpanded_2_0-2.0.pdf

320078 PHS398_ResearchPlan_4_0-4.0.pdf

320078 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

320078 RR_Budget_1_4-1.4.pdf

320078 RR_SubawardBudget30_1_4-1.4.pdf

320078 PHS398_ModularBudget_1_2-1.2.pdf

320078 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 3

Mandatory forms

320078 RR_SF424_5_0-5.0.pdf

320078 PHS398_CoverPageSupplement_5_0-5.0.pdf

320078 RR_OtherProjectInfo_1_4-1.4.pdf

320078 PerformanceSite_4_0-4.0.pdf

320078 RR_KeyPersonExpanded_4_0-4.0.pdf

320078 PHS398_ResearchPlan_4_0-4.0.pdf

320078 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

320078 RR_Budget_3_0-3.0.pdf

320078 RR_SubawardBudget30_3_0-3.0.pdf

320078 PHS398_ModularBudget_1_2-1.2.pdf

320078 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T08:43:01-05:00

Share This Post, Choose Your Platform!

About the Author: